PBSV Stock Financial Analysis - Pharma-Bio Serv, Inc. (OTCPK) Stock

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Pharma-Bio Serv, Inc. as of April 30, 2025 is 9.64 MM.
The operating income for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.73 MM.
The net income for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.19 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-04-30	9.64	-0.73	-0.19
2025-01-31	9.60	-0.94	-0.50
2024-10-31	9.51	-1.29	-0.78
2024-07-31	10.77	-1.19	-0.84
2024-04-30	12.93	-0.34	-0.01
2024-01-31	15.12	0.35	0.61
2023-10-31	16.98	1.12	1.31
2023-07-31	18.02	1.34	1.53
2023-04-30	18.21	1.25	1.29
2023-01-31	18.62	1.15	1.13
2022-10-31	19.40	1.17	1.01
2022-07-31	20.36	-3.79	-4.04
2022-04-30	20.57	-3.80	-2.05
2022-01-31	20.65	-3.82	-2.05
2021-10-31	20.12	-3.85	-2.09
2021-07-31	19.54	1.10	2.93
2021-04-30	20.83	1.55	1.34
2021-01-31	21.44	2.01	1.79
2020-10-31	21.56	2.23	2.05
2020-07-31
2020-04-30

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-04-30
2025-01-31	-0.02	-0.02
2024-10-31	-0.03	-0.03
2024-07-31	-0.04	-0.04
2024-04-30
2024-01-31	0.03	0.03
2023-10-31	0.06	0.06
2023-07-31	0.07	0.07
2023-04-30	0.06	0.06
2023-01-31	0.05	0.05
2022-10-31	0.04	0.04
2022-07-31	-0.18	-0.18
2022-04-30	-0.09	-0.09
2022-01-31	-0.09	-0.09
2021-10-31	-0.09	-0.09
2021-07-31	0.13	0.13
2021-04-30	0.06	0.06
2021-01-31	0.08	0.08
2020-10-31	0.09	0.09
2020-07-31	0.10	0.10
2020-04-30	0.09	0.09

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Pharma-Bio Serv, Inc. as of April 30, 2025 is -1.32 MM.
The cash from investing activities for Pharma-Bio Serv, Inc. as of April 30, 2025 is 1.62 MM.
The cash from financing activities for Pharma-Bio Serv, Inc. as of April 30, 2025 is -1.74 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-04-30	-1.32	1.62	-1.74
2025-01-31	-1.72	4.39	-1.73
2024-10-31	-0.57	-1.36	-1.73
2024-07-31	-0.34	5.79	-1.73
2024-04-30	1.29	-4.07	-1.74
2024-01-31	1.74	-0.78	-1.77
2023-10-31	1.89	-4.22	-1.76
2023-07-31	1.84	-11.56	-1.76
2023-04-30	1.99	-5.38	-1.76
2023-01-31	1.80	-8.22	-1.75
2022-10-31	0.59	-0.02	-3.53
2022-07-31	1.29	-0.01	-3.49
2022-04-30	0.63	-0.01	-3.48
2022-01-31	-0.11	0.05	-3.53
2021-10-31	0.80	1.30	-1.75
2021-07-31	0.18	1.29	-1.79
2021-04-30	0.96	1.30	-1.79
2021-01-31	0.59	1.23	1.93
2020-10-31	1.51	-0.03	0.20
2020-07-31
2020-04-30

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/book for Pharma-Bio Serv, Inc. as of April 30, 2025 is 1.24.
The p/tbv for Pharma-Bio Serv, Inc. as of April 30, 2025 is 1.24.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-04-30		1.24	1.24
2025-01-31	-19.19	1.09	1.09
2024-10-31	-17.75	1.09	1.09
2024-07-31		1.05	1.05
2024-04-30		1.18	1.18
2024-01-31		1.48	1.48
2023-10-31		1.21	1.21
2023-07-31
2023-04-30	17.92	1.19	1.19
2023-01-31	19.60	1.19	1.19
2022-10-31	-4.88	1.22	1.22
2022-07-31	-8.92	1.15	1.15
2022-04-30	0.00
2022-01-31	7.64	0.94	0.94
2021-10-31	8.10	0.99	0.99
2021-07-31	0.00
2021-04-30	16.10	1.00	1.00
2021-01-31	7.29	0.66	0.66
2020-10-31	6.27	0.66	0.66
2020-07-31	9.07	0.96	0.96
2020-04-30	10.18	0.99	0.99

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.06.
The ebit (3y)/ev for Pharma-Bio Serv, Inc. as of April 30, 2025 is 0.09.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-04-30	-0.06	0.09
2025-01-31	-0.09	0.06
2024-10-31	-0.09	0.08
2024-07-31	0.10	-0.04
2024-04-30	0.08	0.02
2024-01-31	0.13	0.03
2023-10-31	0.12	0.03
2023-07-31	0.09	0.01
2023-04-30	0.11	0.04
2023-01-31	0.23	0.09
2022-10-31	-0.70	-0.21
2022-07-31	-0.36	0.13
2022-04-30	0.12	-0.05
2022-01-31	0.52	0.42
2021-10-31	0.34	0.29
2021-07-31
2021-04-30	0.25	0.34
2021-01-31	-8.97	-7.89
2020-10-31	38.15	24.34
2020-07-31	0.45	0.29
2020-04-30	0.29	0.17

Management Effectiveness

The roa for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.03.
The roe for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.04.
The roic for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.04.
The croic for Pharma-Bio Serv, Inc. as of April 30, 2025 is 0.07.
The ocroic for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.14.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-04-30	-0.03	-0.04	-0.04	0.07	-0.14
2025-01-31	-0.04	-0.05	-0.06	-0.26	-0.04
2024-10-31	-0.04	-0.05	-0.06	0.26	-0.02
2024-07-31	0.03	0.04	0.04	-0.06	0.12
2024-04-30	0.03	0.04	0.04	-0.06	0.12
2024-01-31	0.06	0.08	0.04	-0.05	0.11
2023-10-31	0.07	0.09	0.08	-0.24	0.11
2023-07-31	0.06	0.07	0.09	-0.69	0.11
2023-04-30	0.05	0.06	0.06	-0.47	0.10
2023-01-31	0.05	0.06	0.06	-0.47	0.10
2022-10-31	-0.17	-0.21	0.06	-0.18	0.03
2022-07-31	-0.07	-0.10	-0.12	-0.18	0.04
2022-04-30	-0.07	-0.10	-0.11	-0.20	-0.01
2022-01-31	0.10	-0.10	-0.11	-0.20	0.01
2021-10-31	0.10	0.13	0.11	-0.01	0.01
2021-07-31	0.05	0.06	0.06	0.02	0.04
2021-04-30	0.05	0.06	0.06	0.02	0.04
2021-01-31	0.08	0.10	0.08	0.06	0.06
2020-10-31	0.09	0.11	0.09	0.08	0.03
2020-07-31	0.09	0.11	0.10	0.08	0.03
2020-04-30	0.08	0.10	0.09	0.01	-0.05

Gross Margins

The gross margin for Pharma-Bio Serv, Inc. as of April 30, 2025 is 0.29.
The net margin for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.05.
The operating margin for Pharma-Bio Serv, Inc. as of April 30, 2025 is -0.10.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-04-30	0.29	-0.05	-0.10
2025-01-31	0.26	-0.08	-0.14
2024-10-31	0.25	-0.08	-0.11
2024-07-31	0.25	0.04	0.02
2024-04-30	0.29	0.04	0.02
2024-01-31	0.30	0.08	0.07
2023-10-31	0.29	0.08	0.07
2023-07-31	0.26	0.08	0.07
2023-04-30	0.26	0.06	0.06
2023-01-31	0.25	0.06	0.06
2022-10-31	0.26	0.05	0.06
2022-07-31	0.25	-0.10	-0.18
2022-04-30	0.26	-0.10	-0.18
2022-01-31	0.27	-0.10	-0.18
2021-10-31	0.27	0.15	0.06
2021-07-31	0.28	0.06	0.07
2021-04-30	0.28	0.06	0.07
2021-01-31	0.31	0.10	0.10
2020-10-31	0.32	0.11	0.12
2020-07-31	0.32	0.11	0.12
2020-04-30	0.33	0.11	0.10